A round-up of active tender and funding opportunities that may be of interest to Cochrane contributors, authors, and groups - updated through the month.
- Additional funding resources
- Download an Excel list of UK health evidence funders (last updated March 2021)
Wellcome : Discovery Awards
Country funding open to: They will fund applicants based in the UK, the Republic of Ireland and low- and middle-income countries, and coapplicants from the rest of the world if applying as part of a team.
General Information: Wellcome has announced its some of its new funding streams that follow on from the announcement of its new strategy at the end of last year. Wellcome states, ‘We will fund discovery research exploring life, health and wellbeing across a wide range of disciplines, seeking insights that can inspire future improvements in health. And we will bring together expertise across science, innovation and society to develop equitable solutions to the challenges of mental health, global heating, and infectious diseases’. The Discovery Research grant schemes will open in August of 2021 and are open to research from any discipline. The areas are Wellcome Early-Career Awards, Wellcome Career Development Awards, Wellcome Discovery Awards. Announcement of the funding schemes for mental health, global heating, and infectious disease are still to come.
Coronavirus Funding Monitor
General Information: A curated list of open funding calls and other support for researchers, non-profit organizations and commercial organizations, specifically for COVID-19 and coronavirus-related research. Updated daily.
NIH (USA) Open calls related to Coronavirus
Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
More info: https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-031.html
National Institute of Allergy and Infectious Diseases (NIAID)
PA-19-052 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
PA-19-053 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
PA-19-056 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
PA-19-272 PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
PA-19-270 PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
NERC: urgency grants
General Information: The NERC Urgency Grant scheme exists to provide funding for unexpected and transient scientific opportunities created by unpredictable natural events. NERC welcome Urgency proposals related to the current Coronavirus outbreak. The maximum funding that may be sought for an Urgency proposal is £65,000; this limit applies to the total (100%) full economic cost of the project, of which NERC will fund 80%.
NIHR: Travel and subsistence funding to support LMIC engagement during the COVID-19 outbreak
Country funding open to: UK
General Information: The awards will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to COVID-19 in low and middle-income countries.The awards are open to applicants who have a substantive position at a UK higher education institution or research organisation. Applications are open until further notice, on a rolling basis. Applications should ideally be submitted at least 2 weeks before the planned travel.
Who should apply: Relevant Cochrane Groups
Country funding open to: UK
General information: AHRQ Small Research Grant Program is offering amounts of 100,000 for a max of two years. The grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Closing date: Varied - July 16, Nov 16 2021
A list of COVID funding opportunities compiled by Fogarty (USA) for international researchers: Coronavirus news, funding and resources for global health researchers
NIHR Evidence Synthesis Programme Grant Scheme
Country funding open to:
- The lead applicant must be based in England
- Applicants must partner with a Cochrane Review Group (CRG) or Co-Chair of a Campbell Coordinating Review Group (CCG)
- A co-applicant on the grant application is expected to be a Coordinating Editor of a CRG or Co-Chair of a CCG
- Where the Coordinating Editor/Co-Chair is outside of England, an active England-based Editor/Chair of the relevant CRG/CCG must be included as an applicant
- Where appropriate, and in particular to demonstrate collaborative working to improve efficiency, applications could involve more than one CRG/CCG or Coordinating Editor/Co-Chair of a CRG/CCG
General Information: The NIHR Evidence Synthesis Programme Grant Scheme was established to provide high quality evidence synthesis and systematic reviews that will be of direct benefit to users of the NHS and social care services in England. Full applications are now invited for a new round of the scheme.
Grants will be for up to £150,000 for an 18-month project. Grants will be awarded to support a programme of work that includes both new reviews; updating of existing reviews; a suite of methodologically complex reviews; and reviews that demonstrate meeting a clear NHS and/or social care need. Reviews on the integration between the NHS and social care services are highly encouraged. Applications seeking less than the maximum grant value will receive equal consideration.
Priority will be given to applicants who demonstrate an ability and willingness to collaborate with colleagues in order to improve efficiency. Applicants must demonstrate how they have prioritised their proposed topics, for example by completing a Priority Setting Partnership with the James Lind Alliance; or other recognised methodology to meet your requirements.
Closing date: 23 August 2021 – Application deadline (Mid-November 2021; applications will be discussed at the Commissioning Committee meeting and approximately April 2022 projects to start).
Cochrane review gold open access scheme
Who should apply: UK Cochrane Groups
Country funding open to: UK
General info: Cochrane Review Authors can apply to have their reviews published under Gold open access, meaning that they are instantly and freely open for all users to access on the Cochrane Library from the date of publication.
Closing date: 2022
Link to more info: Cochrane review gold open access scheme
If you have a funding opportunity you would like to share, please send the following information to Lydia Parsonson (firstname.lastname@example.org) - Name of funding Opportunity, who should apply, country funding open to, general information, closing date, link to more information.